Speakers
Sacha Bhinder, MD, FRCPC
Scarborough Health Network, Toronto, Ontario

Kenneth R. Chapman, MD, MSc, FRCPC, FACP, FCCP, FERS 
University of Toronto; Toronto, ON

Moderator
Mohit Bhutani, MD, FRCPC, FCCP
University of Alberta, Edmonton, AB

Session Description

This debate will provide the attendees with an up-to-date review of the clinical trial data with “closed” triple inhaled therapy in asthma and their relevance to daily practice. Upon completion of this activity, participants will better understand the respective roles of triple therapy and biologic therapy in their most difficult patients with asthma.

Learning Objectives

At the end of this presentation, attendees will be able to:

  • Review the most recent data on single inhaler triple therapy in asthma
  • Consider whether LAMA should be added to inhaled regimens at GINA Step 4 or Step 5
  • Describe strategies to improve diagnosis and optimize management of severe asthma

CanMEDS Roles: Medical Expert, Communicator, Scholar

This session is co-developed by the CTS and Valeo and is planned to achieve scientific integrity, objectivity and balance.